Liraglutide API Technology

Products

Information

AVVA Pharmaceuticals is seeking partners to license it's developed API manufacturing technology recombinant Liraglutide. This technology encompasses many improvements vs the originator for the production of a cost competitive medicine. Technical support could be provided for the FDF stage

Main Categories

Biopharmaceuticals

All Categories

Bio process technologiesBiopharmaceuticals

AVVA Pharmaceuticals LtdAVVA Pharmaceuticals Ltd is a European based pharmaceutical company, aiming on becoming a reference innovation hub for the development of biological medicines and new small molecules, with ultimate goal on providing a meaningful and affordable healthcare. The company focuses on developing biosimilars and biological medicines in partnership with leading international research and scientific centers. Our portfolio includes a number of inventions that will replace current standards in the fields of infectious and metabolic diseases.

Liraglutide API Technology

Information

Log in